Updates are available Correction dated 2025-10-09
Click to view Correction: https://doi.org/10.1007/s15010-025-02641-6
-
Authors
Shitrit, Itamar Ben
Idan, Daphna
Hasidim, Ariel Avraham
Michael, Tal
Levy, Amalia
Pariente, Gali
Lunenfeld, Eitan
Daniel, Sharon
-
Funding
Funding for this research was provided by:
Ben-Gurion University
- License Information
-
More Information
Article History
Received: 11 June 2025
Accepted: 3 August 2025
First Online: 22 August 2025
Change Date: 9 October 2025
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1007/s15010-025-02641-6
Declarations
:
: The research was approved by SMC’s ethics committee in accordance with the Declaration of Helsinki (study number: 0069–20-SOR, Approval date: 07/03/2022).
: Due to the retrospective nature of the cohort, the ethic committee waived the need of informed consent to participate.
: Due to the retrospective nature of the cohort, the ethic committee waived the need of informed consent to publish.
: Large cohort supports evidence that first-trimester doxycycline exposure does not increase major congenital malformations, even when stillbirths and terminations are included.
: The authors declare no competing interests.
